elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q24202199-0AAF80CF-BA5E-416D-B90C-D879255A3FC0
Q24202199-0AAF80CF-BA5E-416D-B90C-D879255A3FC0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q24202199-0AAF80CF-BA5E-416D-B90C-D879255A3FC0
Vascular-endothelial-growth-factor (VEGF) targeting therapies for endocrine refractory or resistant metastatic breast cancer
P2860
Q24202199-0AAF80CF-BA5E-416D-B90C-D879255A3FC0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q24202199-0AAF80CF-BA5E-416D-B90C-D879255A3FC0
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
bb3c24a4bc52d33617a9aeb4fbddda8cd039b810
P2860
Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer